Pervasis Provides Update On Progress Of Clinical Program Targeting Peripheral Arterial Disease
Links shared publicly online about this topic.
- 1,073total visits
Pervasis Provides Update On Progress Of Clinical Program Targeting Peripheral Arterial Disease
Pervasis Therapeutics announced that the first cohort of patients has been fully enrolled in the Phase 1/2 clinical study of PVS-10200, an investigational new drug under development to prevent res
View full resource at medicalnewstoday.com
Tags: Disease and Condition, Drug
Most Recently Shared on June 24, 2010 at 9:14 am By:
Pervasis Provides Update On Progress Of Clinical Program Targeting Peripheral Arterial Disease http://mnt.to/3Ff9 #clinicaltrials
Also Shared By:
Advertisement
MNT Cardiovascular
@mnt_cardiovasc
Pervasis Provides Update On Progress Of Clinical Program Targeting Peripheral Arterial Disease http://mnt.to/3Ff9 #cardiovascular
1 year ago...